Table 1.
Demographic and clinical characteristics by disease group
| Factor | All(n=148) | NASH(n=53) | HCV(n=95) | p value |
|---|---|---|---|---|
| Male | 112 (75.7) | 32 (60.4) | 80 (84.2) | 0.001 |
| Caucasian | 119 (80.4) | 49 (92.5) | 70 (73.7) | 0.006 |
| Age | 55.4 (50.0, 60.0) | 57.8 (52.3, 63.4) | 54.0 (50.0, 58.0) | 0.005 |
| Triglyceride (n=98) | 153.5 (106.0, 208.0) | 150.0 (115.0, 200.5) | 153.5 (104.0, 212.0) | 0.99 |
| HDL (n=96) | 43.0 (35.0, 52.0) | 43.0 (37.5, 51.0) | 43.0 (34.0, 54.5) | 0.91 |
| Tacrolimus | 128 (86.5) | 48 (90.6) | 80 (84.2) | 0.28 |
| Cyclosporine | 13 (8.8) | 4 (7.6) | 9 (9.5) | 0.77 |
| Mycophenolate mofetil | 53 (35.8) | 21 (39.6) | 32 (33.7) | 0.47 |
| Diabetes post-OLT | 87 (58.8) | 38 (71.7) | 49 (51.6) | 0.017 |
| Hypertension post-OLT | 89 (60.1) | 28 (52.8) | 61 (64.2) | 0.18 |
| BMI @1 yr post-OLT (n=136) | 28.6 (24.3, 31.9) | 30.9 (26.7, 34.1) | 27.1 (23.9, 30.1) | <0.001 |
| MS @1 yr post-OLT (n=123) | 65 (52.9) | 24 (58.5) | 41 (50.0) | 0.37 |
| Acute cellular rejection | 65 (43.9) | 22 (41.5) | 43 (45.3) | 0.66 |
| Steroids | 34 (23.6) | 3 (5.7) | 31 (34.1) | <0.001 |
| Total FU months (OLT to last Bx) | 12.7 (5.9, 26.3) | 5.1 (0.69, 13.4) | 19.6 (11.9, 30.0) | <0.001 |
| Steatosis | 64 (43.2) | 17 (32.1) | 47 (49.5) | 0.041 |
| Fibrosis | 69 (46.6) | 10 (18.9) | 59 (62.1) | <0.001 |
Values are presented as n(%) or Median (25%ile, 75%ile)
p values correspond to Pearson’s ϰ2 tests for categorical factors and Wilcoxon rank sum tests for continuous variables